FTCM
RNAM

First Trust Capital Management’s Avidity Biosciences RNAM Stock Holding History

First Trust Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,000
Closed -$2.89M – 200
2025
Q4 		$2.89M Buy
+40,000
New +$2.58M 0.17% 116

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

First Trust Capital Management's RNAM Position: Q1 2026 in Review

First Trust Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 40,000 shares — an estimated $2.89M sold.

First Trust Capital Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $2.89M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • First Trust Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • First Trust Capital Management sold 40,000 Avidity Biosciences shares in Q1 2026, an estimated $2.89M.
  • First Trust Capital Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • First Trust Capital Management's Avidity Biosciences position peaked at $2.89M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on First Trust Capital Management's 13F filing for Q1 2026, filed 14 May 2026.